Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9918428rdf:typepubmed:Citationlld:pubmed
pubmed-article:9918428lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9918428lifeskim:mentionsumls-concept:C0014597lld:lifeskim
pubmed-article:9918428lifeskim:mentionsumls-concept:C0009368lld:lifeskim
pubmed-article:9918428lifeskim:mentionsumls-concept:C0005390lld:lifeskim
pubmed-article:9918428lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:9918428lifeskim:mentionsumls-concept:C1819461lld:lifeskim
pubmed-article:9918428pubmed:issue12lld:pubmed
pubmed-article:9918428pubmed:dateCreated1999-6-15lld:pubmed
pubmed-article:9918428pubmed:abstractTextTo clarify the regulatory mechanism of the production of various inflammatory mediators by intestinal epithelial cells, the effect of bile acids (tauroursodeoxycholate, TUDC; taurochenodeoxycholate, TCDC; and taurocholate, TC) on the cytokine-induced production of interleukin (IL)-8 in a human colon epithelial cell line (HT-29) was examined. HT-29 cells were incubated for 24 h in a culture medium containing tumour necrosis factor alpha (TNF alpha; 1 ng/mL) and/or interleukin (IL)-1beta (1 ng/mL) in the presence or absence of bile acids. The IL-8 concentration in the medium was measured by an enzyme-linked immunosorbent assay. The binding assay of TNF alpha was performed using [125I]-TNF alpha (100 pmol/L). Interleukin-8 production during incubation with TNF alpha was markedly reduced in the presence of 0.5 and 1 mmol/LTUDC, 0.5 and 1 mmol/LTCDC and 0.5 and 1 mmol/LTC, by 56, 85, 86, 91, 37 and 70%, respectively. The IL-8 production during incubation with IL-1beta was not significantly reduced in the presence of these bile acids. The specific binding of TNF alpha to cells was inhibited 33, 47, and 14% by 1 mmol/LTUDC, TCDC and TC, respectively. These findings suggest that bile acids inhibit TNF alpha-induced IL-8 production by the colonic cells. The suppression may be partly due to inhibition of TNF alpha binding to the cells by bile acids.lld:pubmed
pubmed-article:9918428pubmed:languageenglld:pubmed
pubmed-article:9918428pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9918428pubmed:citationSubsetIMlld:pubmed
pubmed-article:9918428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9918428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9918428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9918428pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9918428pubmed:statusMEDLINElld:pubmed
pubmed-article:9918428pubmed:monthDeclld:pubmed
pubmed-article:9918428pubmed:issn0815-9319lld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:NakagawaKKlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:UchidaKKlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:TanakaSSlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:KojimaKKlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:HirataIIlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:TeranishiTTlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:SugiKKlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:KatsuKKlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:SaitohOOlld:pubmed
pubmed-article:9918428pubmed:authorpubmed-author:MatsuseRRlld:pubmed
pubmed-article:9918428pubmed:issnTypePrintlld:pubmed
pubmed-article:9918428pubmed:volume13lld:pubmed
pubmed-article:9918428pubmed:ownerNLMlld:pubmed
pubmed-article:9918428pubmed:authorsCompleteYlld:pubmed
pubmed-article:9918428pubmed:pagination1212-7lld:pubmed
pubmed-article:9918428pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:meshHeadingpubmed-meshheading:9918428-...lld:pubmed
pubmed-article:9918428pubmed:year1998lld:pubmed
pubmed-article:9918428pubmed:articleTitleBile acids inhibit tumour necrosis factor alpha-induced interleukin-8 production in human colon epithelial cells.lld:pubmed
pubmed-article:9918428pubmed:affiliationSecond Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan. Saitoh@poh.osaka-med.ac.jplld:pubmed
pubmed-article:9918428pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9918428pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed